Cargando…
Glycosphingolipid Levels in Urine Extracellular Vesicles Enhance Prediction of Therapeutic Response in Lupus Nephritis
The development of nephritis increases the risk of morbidity and mortality in systemic lupus erythematosus (SLE) patients. While standard induction therapies, such as mycophenolate mofetil (MMF) induce clinical remission (i.e., complete response) in approximately 50% of SLE patients with nephritis,...
Autores principales: | Troyer, Brian, Rodgers, Jessalyn, Wolf, Bethany J., Oates, James C., Drake, Richard R., Nowling, Tamara K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876142/ https://www.ncbi.nlm.nih.gov/pubmed/35208209 http://dx.doi.org/10.3390/metabo12020134 |
Ejemplares similares
-
Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice
por: Nowling, Tamara K., et al.
Publicado: (2020) -
Metabolic Markers and Association of Biological Sex in Lupus Nephritis
por: Wolf, Bethany, et al.
Publicado: (2023) -
Mechanisms of tissue injury in lupus nephritis
por: Nowling, Tamara K, et al.
Publicado: (2011) -
Structure and function of glycosphingolipids on small extracellular vesicles
por: He, Xin, et al.
Publicado: (2022) -
Reducing FLI1 Levels in the MRL/lpr Lupus Mouse Model Impacts T Cell Function by Modulating Glycosphingolipid Metabolism
por: Richard, Erin Morris, et al.
Publicado: (2013)